SecurityAGN / Allergan plc
InstitutionAchmea Investment Management B.V.
Shares9,573
Value $ 1,596,000
Related ACT / Actavis
018490AP7 / Allergan, Inc. 1.35% 03/15/18
018490AQ5 / Allergan, Inc. 2.80% 03/15/23
018490AM4 / Allergan Inc. 5.75% Senior Notes 4/1/16
018490AN2 / Allergan Inc Fixed Rt Notes 3.375% 09/15/2020
AGN.PRA / Allergan plc
G0084GLX2 / Allergan plc Bond
942683AF0 / Watson Pharmaceuticals I 3.25% 10/01/2022
942683AD5 / Watson Pharmaceuticals Inc Notes 5% 08/15/14
942683AE3 / Watson Pharmaceuticals Inc Notes 6.125% 08/15/19

Achmea Investment Management B.V. ownership in AGN / Allergan plc

July 27, 2018 - Achmea Investment Management B.V. has filed a 13F-HR form disclosing ownership of 9,573 shares of Allergan plc (NYSE:AGN) with total holdings valued at $1,596,000 USD as of June 30, 2018. Achmea Investment Management B.V. had filed a previous 13F-HR on May 15, 2018 disclosing 9,573 shares of Allergan plc at a value of $1,611,000 USD. This represents a change in shares of 0.00 percent and a change in value of -0.93 percent during the quarter.

Other investors with positions similar to Achmea Investment Management B.V. include United Capital Financial Advisers, Llc, Cutler Group LP, Tributary Capital Management, LLC, Bessemer Group Inc, Armstrong Shaw Associates Inc/ct, and Levin Capital Strategies, L.p..

Allergan plc has declared a standard industrial code (sic) of 2834 which is the "Pharmaceutical Preparations" industry. Achmea Investment Management B.V.'s top industries are "Automotive Repair, Services, And Parking" (sic 75), "Printing, Publishing, And Allied Industries" (sic 27), and "Textile Mill Products" (sic 22).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR Allergan AGN US G0177J108 167.50 9,573 0.00 1,596 -0.93 0 -15 -0.93
2018-03-31 13F-HR Allergan AGN US G0177J108 165.88 9,573 0.00 1,611 2.94 0 46 2.94
2017-12-31 13F-HR Allergan AGN US G0177J108 184.21 9,573 72.39 1,565 37.52 741 -314 -27.55
2017-09-30 13F-HR Allergan AGN US G0177J108 223.93 5,553 0.00 1,138 -15.64 0 -211 -15.64
2017-06-30 13F-HR/A-1 Allergan AGN US G0177J108 240.93 5,553 -77.22 1,349 -76.84 -4,535 60 1.03
2017-03-31 13F-HR/A-1 Allergan AGN US G0177J108 238.92 24,376 0.00 5,824 0.00 0 0 0.00
2017-03-31 13F-HR Allergan AGN US G0177J108 24,376 5,824


CUSIP: G0177J108